{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T18:51:01Z","timestamp":1789757461125,"version":"4.0.1"},"reference-count":51,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,9,5]],"date-time":"2025-09-05T00:00:00Z","timestamp":1757030400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:sec><jats:title>Introduction<\/jats:title><jats:p>Symptoms resembling myalgic encephalomyelitis\/chronic fatigue syndrome (ME\/CFS) frequently affect patients with rheumatic diseases, but little is known about their frequency and disease manifestations, particularly in systemic sclerosis (SSc) patients. We sought to determine if severe fatigue in SSc patients with early disease (&amp;lt; 7 years) is associated with increased disability, inflammation and fibrosis.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>In this exploratory cross-sectional study, 51 SSc patients were recruited locally (UofA cohort). Disability, disease damage accrual, inflammatory markers and, indicators of fibrotic and vascular complications (e.g. lung function, nailfold capillaroscopy) were compared between patients with and without severe fatigue. Fatigue was assessed using validated questionnaires (e.g. FACIT, MFI) and ME\/CFS criteria. Findings were further corroborated in the national CSRG (Canadian Scleroderma Research Group) SSc cohort (n=126).<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>SSc patients with severe fatigue had significantly increased disability, reduced lung function capacity, and elevated Galectin-9 levels when compared to patients without fatigue. Galectin-9 levels correlated with reduced pulmonary function, and increased disease damage accrual. Further analysis in the UofA cohort suggested that indictors associated with disease progression such as reduced nailfold capillary density, and elevated VEGF, LT\u03b1 and IL-16 were present in severely fatigued patients.<\/jats:p><\/jats:sec><jats:sec><jats:title>Discussion<\/jats:title><jats:p>Severe fatigue in SSc patients is associated with increased disability, reduced pulmonary function and increased vascular remodeling. We propose that ME\/CFS-like symptoms in patients with SSc may be indicative of sub-clinical inflammation and fibrosis. Further studies are required to determine whether Gal-9,may be a useful tool for the stratification of SSc patients - particularly those with severe fatigue resembling ME\/CFS.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fimmu.2025.1655414","type":"journal-article","created":{"date-parts":[[2025,9,5]],"date-time":"2025-09-05T13:11:38Z","timestamp":1757077898000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":2,"title":["Severe fatigue is associated with diminished lung function and elevated Galectin-9 levels in early systemic sclerosis"],"prefix":"10.3389","volume":"16","author":[{"given":"Charmaine","family":"van Eeden","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maryam","family":"Rezaeifar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammad","family":"Elezzabi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Desiree","family":"Redmond","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Gniadecki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Abey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erin","family":"Reynolds","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dalton","family":"Sholter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shima","family":"Shahbaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shokrollah","family":"Elahi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lamia","family":"Khan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Mason","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marvin J.","family":"Fritzler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Douwe J.","family":"Mulder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Murray","family":"Baron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maggie J.","family":"Larch\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janet","family":"Pope","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"May","family":"Choi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabrina","family":"Hoa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carter","family":"Thorne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Nethchiporouk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan Willem","family":"Cohen Tervaert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammed S.","family":"Osman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,9,5]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2013-203716","article-title":"Preliminary analysis of the very early diagnosis of systemic sclerosis (VEDOSS) EUSTAR multicenter study: evidence for puffy fingers as a pivotal sign for suspicion of systemic sclerosis","volume":"73","author":"Minier","year":"2014","journal-title":"Ann Rheum Dis"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1080\/1744666X.2022.2116002","article-title":"Fatigue in ANCA-associated vasculitis and systemic sclerosis (SSc): similarities with Myalgic encephalomyelitis\/chronic fatigue syndrome (ME\/CFS)","volume":"18","author":"van Eeden","year":"2022","journal-title":"A Crit Rev literature. Expert Rev Clin Immunol"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.3390\/jcm9113463","article-title":"Systematic review of primary outcome measurements for chronic fatigue syndrome\/myalgic encephalomyelitis (CFS\/ME) in randomized controlled trials","volume":"9","author":"Kim","year":"2020","journal-title":"J Clin Med"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1341843","article-title":"Metabolomic and immune alterations in long COVID patients with chronic fatigue syndrome","volume":"15","author":"Saito","year":"2024","journal-title":"Front Immunol"},{"key":"B5","doi-asserted-by":"publisher","first-page":"103267","DOI":"10.1016\/j.jaut.2024.103267","article-title":"Diverse immunological dysregulation, chronic inflammation, and impaired erythropoiesis in long COVID patients with chronic fatigue syndrome","volume":"147","author":"Saito","year":"2024","journal-title":"J Autoimmun"},{"key":"B6","doi-asserted-by":"publisher","first-page":"100460","DOI":"10.1016\/j.lana.2023.100460","article-title":"Myalgic encephalomyelitis\/chronic fatigue syndrome (ME\/CFS) and fibromyalgia: PR3-versus MPO-ANCA-associated vasculitis, an exploratory cross-sectional study","volume":"20","author":"van Eeden","year":"2023","journal-title":"Lancet Reg Health Am"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.3390\/ijms241512057","article-title":"Evidence of a novel mitochondrial signature in systemic sclerosis patients with chronic fatigue syndrome","volume":"24","author":"van Eeden","year":"2023","journal-title":"Int J Mol Sci"},{"key":"B8","article-title":"Fatigue in systemic sclerosis: a systematic review","author":"Basta","year":"2018","journal-title":"Clin Exp Rheumatol"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.02026-2019","article-title":"Predictors of progression in systemic sclerosis patients with interstitial lung disease","volume":"55","author":"Distler","year":"2020","journal-title":"Eur Respir J"},{"key":"B10","doi-asserted-by":"publisher","first-page":"104883","DOI":"10.1016\/j.ebiom.2023.104883","article-title":"High serum C-X-C motif chemokine ligand 10 (CXCL10) levels may be associated with new onset interstitial lung disease in patients with systemic sclerosis: evidence from observational, clinical, transcriptomic and in vitro studies","volume":"98","author":"Al-Adwi","year":"2023","journal-title":"EBioMedicine"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1002\/art.43120","article-title":"Serum Type I Interferon Score predicts clinically meaningful disease progression in limited cutaneous Systemic Sclerosis","volume":"77","author":"Di Donato","year":"2025","journal-title":"Arthritis Rheumatol"},{"key":"B12","doi-asserted-by":"publisher","first-page":"69","DOI":"10.4103\/ejb.ejb_22_17","article-title":"Serum\u00a0interleukin 23 and its associations with interstitial lung disease and clinical manifestations of scleroderma","author":"Hammad","year":"2018","journal-title":"Egyptian J Bronchology"},{"key":"B13","doi-asserted-by":"publisher","first-page":"4309485","DOI":"10.1155\/2017\/4309485","article-title":"Cytokines as biomarkers and their respective clinical cutoff levels","volume":"2017","author":"Monastero","year":"2017","journal-title":"Int J Inflam"},{"key":"B14","doi-asserted-by":"publisher","first-page":"114200","DOI":"10.1016\/j.celrep.2024.114200","article-title":"Circadian-clock-controlled endocrine and cytokine signals regulate multipotential innate lymphoid cell progenitors in the bone marrow","volume":"43","author":"Lui","year":"2024","journal-title":"Cell Rep"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1038\/s41577-022-00829-7","article-title":"The role of galectins in immunity and infection","volume":"23","author":"Liu","year":"2023","journal-title":"Nat Rev Immunol"},{"key":"B16","doi-asserted-by":"publisher","first-page":"9473243","DOI":"10.1155\/2018\/9473243","article-title":"Clinical significance of serum galectin-9 and soluble CD155 levels in patients with systemic sclerosis","volume":"2018","author":"Chihara","year":"2018","journal-title":"J Immunol Res"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1016\/j.jid.2017.04.035","article-title":"Systemic Sclerosis Dermal Fibroblasts Suppress Th1 Cytokine Production via Galectin-9 Overproduction due to Fli1 Deficiency","volume":"137","author":"Saigusa","year":"2017","journal-title":"J Invest Dermatol"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2021.628128","article-title":"Aberrantly expressed galectin-9 is involved in the immunopathogenesis of anti-MDA5-positive dermatomyositis-associated interstitial lung disease","volume":"9","author":"Liang","year":"2021","journal-title":"Front Cell Dev Biol"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2013-204424","article-title":"classification criteria for systemic sclerosis: an American College of Rheumatology\/European League against Rheumatism collaborative initiative","volume":"65","author":"van den Hoogen","year":"2013","journal-title":"Arthritis Rheum"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2012.05.011","article-title":"Autoantibodies in systemic sclerosis","volume":"12","author":"Mehra","year":"2013","journal-title":"Autoimmun Rev"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1002\/art.24038","article-title":"Autoantibodies and microvascular damage are independent predictive factors for the progression of Raynaud's phenomenon to systemic sclerosis: a twenty-year prospective study of 586 patients, with validation of proposed criteria for early systemic sclerosis","volume":"58","author":"Koenig","year":"2008","journal-title":"Arthritis Rheum"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2021.708432","article-title":"Nailfold capillaroscopy abnormalities correlate with disease activity in adult dermatomyositis","volume":"8","author":"Johnson","year":"2021","journal-title":"Front Med (Lausanne)"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1002\/art.43051","article-title":"Characterization of incident interstitial lung disease in late systemic sclerosis","volume":"77","author":"Hoa","year":"2024","journal-title":"Arthritis Rheumatol"},{"key":"B24","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1300\/J092v11n01_02","article-title":"Myalgic encephalomyelitis\/chronic fatigue syndrome","volume":"11","author":"Carruthers","year":"2003","journal-title":"J Chronic Fatigue Syndrome"},{"key":"B25","doi-asserted-by":"publisher","first-page":"9","DOI":"10.3389\/fneur.201801033","article-title":"Neuroinflammation and cytokines in myalgic encephalomyelitis\/chronic fatigue syndrome (ME\/CFS): A critical review of research methods","volume":"2019","author":"van Elzakker","year":"1033","journal-title":"Front Neurol"},{"key":"B26","volume-title":"Stata statistical software: release 18","year":"2023"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1111\/cei.12580","article-title":"Natural killer cell subsets in cerebrospinal fluid of patients with multiple sclerosis","volume":"180","author":"Rodriguez-Martin","year":"2015","journal-title":"Clin Exp Immunol"},{"key":"B28","doi-asserted-by":"publisher","first-page":"267","DOI":"10.21926\/obm.neurobiol.2501267","article-title":"Measuring post-exertional malaise with dePaul symptom questionnaires: challenges and opportunities","volume":"9","author":"Jason","year":"2025","journal-title":"OBM Neurobiol"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1002\/art42861","article-title":"American college of rheumatology (ACR)\/American college of chest physicians (CHEST) guideline for the screening and monitoring of interstitial lung disease in people with systemic autoimmune rheumatic diseases","volume":"76","author":"Johnson","year":"2023","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1007\/s00281-015-0511-7","article-title":"Cytokines in the immunopathology of systemic sclerosis","volume":"37","author":"Raja","year":"2015","journal-title":"Semin Immunopathol"},{"key":"B31","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/j.semarthrit.2017.02.006","article-title":"Sequential nailfold videocapillaroscopy examinations have responsiveness to detect organ progression in systemic sclerosis","volume":"47","author":"Avouac","year":"2017","journal-title":"Semin Arthritis Rheum"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.140276","article-title":"Association between nailfold capillaroscopy findings and pulmonary function tests in patients with systemic sclerosis","volume":"42","author":"Castellvi","year":"2015","journal-title":"J Rheumatol"},{"key":"B33","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1186\/s13075-018-1775-9","article-title":"Quantitative videocapillaroscopy correlates with functional respiratory parameters: a clue for vasculopathy as a pathogenic mechanism for lung injury in systemic sclerosis","volume":"20","author":"Guillen-Del-Castillo","year":"2018","journal-title":"Arthritis Res Ther"},{"key":"B34","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1186\/s13075-018-1519-x","article-title":"A unique role for galectin-9 in angiogenesis and inflammatory arthritis","volume":"20","author":"O'Brien","year":"2018","journal-title":"Arthritis Res Ther"},{"key":"B35","doi-asserted-by":"publisher","first-page":"103391","DOI":"10.1016\/j.jaut.2025.103391","article-title":"Total lung capacity is predictive of disease severity and survival in systemic sclerosis: A longitudinal analysis in 2347 patients from the French National Cohort Study","volume":"152","author":"Chaigne","year":"2025","journal-title":"J Autoimmun"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1128\/mBio.00384-21","article-title":"Galectin-9, a player in cytokine release syndrome and a surrogate diagnostic biomarker in SARS-coV-2 infection","volume":"12","author":"Bozorgmehr","year":"2021","journal-title":"mBio"},{"key":"B37","doi-asserted-by":"publisher","first-page":"e3001387","DOI":"10.1371\/journal.pbio.3001387","article-title":"Neutrophils promote T-cell activation through the regulated release of CD44-bound Galectin-9 from the cell surface during HIV infection","volume":"19","author":"Dunsmore","year":"2021","journal-title":"PloS Biol"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.3390\/ijms24044097","article-title":"Current trends in vascular biomarkers for systemic sclerosis: A narrative review","volume":"24","author":"Fioretto","year":"2023","journal-title":"Int J Mol Sci"},{"key":"B39","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1186\/s13075-017-1370-5","article-title":"The \"myth\" of loss of angiogenesis in systemic sclerosis: a pivotal early pathogenetic process or just a late unavoidable event","volume":"19","author":"Matucci-Cerinic","year":"2017","journal-title":"Arthritis Res Ther"},{"key":"B40","article-title":"Expression of Galectin-9 and correlation with disease activity and vascular endothelial growth factor in rheumatoid arthritis","volume":"38","author":"Wang","year":"2020","journal-title":"Clin Exp Rheumatol"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.3390\/ijms20112634","article-title":"Galectin-9 induces mitochondria-mediated apoptosis of esophageal cancer in vitro and in vivo in a xenograft mouse model","volume":"20","author":"Chiyo","year":"2019","journal-title":"Int J Mol Sci"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1093\/jb\/mvm019","article-title":"Characterization of galectin-9-induced death of Jurkat T cells","volume":"141","author":"Lu","year":"2007","journal-title":"J Biochem"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1515\/rjim-2015-0006","article-title":"IL-17, IL-6 and IFN-gamma in systemic sclerosis patients","volume":"53","author":"Balanescu","year":"2015","journal-title":"Rom J Intern Med"},{"key":"B44","doi-asserted-by":"publisher","first-page":"R147","DOI":"10.1186\/ar2821","article-title":"Plasma cytokine profiles in systemic sclerosis: associations with autoantibody subsets and clinical manifestations","volume":"11","author":"Gourh","year":"2009","journal-title":"Arthritis Res Ther"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/kez318","article-title":"IL-16 expression is increased in the skin and sera of patients with systemic sclerosis","volume":"59","author":"Kawabata","year":"2020","journal-title":"Rheumatol (Oxford)"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.080120","article-title":"Increased serum interleukin 23 in patients with systemic sclerosis","volume":"35","author":"Komura","year":"2008","journal-title":"J Rheumatol"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2249.2004.02642.x","article-title":"Cytokine\u00a0and chemokine levels in systemic sclerosis: relationship with cutaneous and internal organ involvement","volume":"138","author":"Scala","year":"2004","journal-title":"Clin Exp Immunol"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.3390\/jcm6090081","article-title":"IL-23 and th17 disease in inflammatory arthritis","volume":"6","author":"Yago","year":"2017","journal-title":"J Clin Med"},{"key":"B49","doi-asserted-by":"publisher","first-page":"6647","DOI":"10.1038\/s41598-023-31232-4","article-title":"Circulating cytokine levels in systemic sclerosis related interstitial lung disease and idiopathic pulmonary fibrosis","volume":"13","author":"Zheng","year":"2023","journal-title":"Sci Rep"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1002\/j.1460-2075.1990.tb07879.x","article-title":"Interferon selectively inhibits the expression of mitochondrial genes: a novel pathway for interferon-mediated responses","volume":"9","author":"Shan","year":"1990","journal-title":"EMBO J"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2018-213497","article-title":"Galectin-9 is an easy to measure biomarker for the interferon signature in systemic lupus erythematosus and antiphospholipid syndrome","volume":"77","author":"van den Hoogen","year":"2018","journal-title":"Ann Rheum Dis"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2025.1655414\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,5]],"date-time":"2025-09-05T13:11:40Z","timestamp":1757077900000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2025.1655414\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,5]]},"references-count":51,"alternative-id":["10.3389\/fimmu.2025.1655414"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2025.1655414","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,5]]},"article-number":"1655414"}}